Shares of 12 pharmaceutical companies fell by 0.82% to 5.8% at 12:52 IST on BSE as the rupee edged higher against the dollar.
IPCA Laboratories (down 5.8%), Glenmark Pharmaceuticals (down 4.88%), Sun Pharmaceutical Industries (down 4.84%), Dr. Reddy's Laboratories (down 4.17%), Ranbaxy Laboratories (down 3.72%), Divi's Laboratories (down 3.65%), Wockhardt (down 3.55%), Aurobindo Pharma (down 3.22%), Lupin (down 3.17%), Cadila Healthcare (down 2.63%), Biocon (down 2.21%) and Cipla (down 0.82%), edged lower.
The S&P BSE Sensex was up 208.39 points, or 0.86% at 24,330.13.
In the foreign exchange market, the rupee edged higher against the dollar on expectations of continued robust foreign buying in domestic shares and debt after the Bharatiya Janata Party (BJPL) swept the country's Lok Sabha elections. The partially convertible rupee was hovering at 58.4450, compared with its close of 58.79/80 on Friday, 16 May 2014.
A firm rupee impacts the value of overseas earnings in local terms. Pharma companies derive substantial revenue from exports.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app